We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+7.15%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$22.3B
AUM Growth
+$851M
(+4%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-0.79%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
1,274
New
347
Increased
260
Reduced
248
Closed
334
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
Analog Devices
ADI
|
+$121M |
| 4 |
United Therapeutics
UTHR
|
+$105M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$97.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$238M |
| 2 |
DXC Technology
DXC
|
+$235M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 4 |
NXP Semiconductors
NXPI
|
+$158M |
| 5 |
Baidu
BIDU
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Healthcare | 19.74% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 7.27% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Insmed
INSM
$22.6B
| $81.8M | 0.37% |
2,875,596
-1,626
| -0.1% | -$48.3K |
|
52
Fidelity National Information Services
FIS
$23.2B
| $80.7M | 0.36% |
569,287
+556,190
| +4,247% | +$82.6M |
|
53
Dominion Energy
D
$62.1B
| $79.9M | 0.36% |
1,086,194
+388,300
| +56% | +$30M |
|
54
Repligen
RGEN
$8.2B
| $79.5M | 0.36% |
398,407
+56,840
| +17% | +$11M |
|
55
American Electric Power
AEP
$72.4B
| $78.9M | 0.35% |
+932,500
| New | +$80.3M |
|
56
CSX Corp
CSX
$94.2B
| $78.6M | 0.35% |
2,449,501
+1,600,357
| +188% | +$52.8M |
|
57
Mondelez International
MDLZ
$80.2B
| $76.4M | 0.34% |
+1,224,248
| New | +$75.4M |
|
58
Microchip Technology
MCHP
$41.1B
| $75.8M | 0.34% |
1,011,812
-100,824
| -9% | -$7.68M |
|
59
VF Corp
VFC
$7.16B
| $74.9M | 0.34% |
912,557
-387,123
| -30% | -$32.3M |
|
60
McDonald's
MCD
$194B
| $74.3M | 0.33% |
321,859
+264,470
| +461% | +$61.5M |
|
61
Sanofi
SNY
$109B
| $74.2M | 0.33% |
1,409,629
+352,229
| +33% | +$18.4M |
|
62
Zoetis
ZTS
$32.5B
| $73.2M | 0.33% |
392,700
+82,400
| +27% | +$14.3M |
|
63
Cenovus Energy
CVE
$51.6B
| $72.3M | 0.32% |
7,558,734
+2,764,961
| +58% | +$23.4M |
|
|
GBT
64
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $72.2M | 0.32% |
2,061,600
+736,118
| +56% | +$28.7M |
|
65
PUT
iShares China Large-Cap ETF
FXI
$4.27B
| $71.9M | 0.32% |
+1,552,100
| New | +$71.7M |
|
66
CrowdStrike
CRWD
$185B
| $71.8M | 0.32% |
1,142,616
+923,924
| +422% | +$49.7M |
|
67
Crown Holdings
CCK
$13.2B
| $71.6M | 0.32% |
700,153
+35,286
| +5% | +$3.72M |
|
|
RDS.B
68
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $70.1M | 0.31% |
1,805,167
+1,127,067
| +166% | +$42.4M |
|
69
CALL
Merck
MRK
$326B
| $70M | 0.31% |
900,000
+376,000
| +72% | +$28M |
|
70
KLA
KLAC
$249B
| $68.9M | 0.31% |
+2,126,000
| New | +$68.1M |
|
71
Teledyne Technologies
TDY
$30.1B
| $68.5M | 0.31% |
163,578
+66,027
| +68% | +$28M |
|
72
Encompass Health
EHC
$11.5B
| $68.5M | 0.31% |
1,103,646
+483,191
| +78% | +$32.2M |
|
73
Comcast
CMCSA
$85.8B
| $68M | 0.31% |
1,192,778
+947,978
| +387% | +$53M |
|
74
Ultragenyx Pharmaceutical
RARE
$2.56B
| $67.4M | 0.3% |
707,300
+587,700
| +491% | +$61.2M |
|
75
Capri Holdings
CPRI
$1.88B
| $66.9M | 0.3% |
1,170,617
-300,073
| -20% | -$16.3M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Point72 Asset Management held 1,274 positions worth $22.3B, up 4% from $21.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Point72 Asset Management's Q2 2021 filing shows 347 new, 260 increased, 248 reduced and 334 closed positions. Its largest new stake was United Therapeutics: 552,400 shares worth $99.1M. The largest sale was Applied Materials, an estimated $238M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Point72 Asset Management's largest Q2 2021 buy was United Therapeutics: 552,400 shares worth $99.1M.
- Point72 Asset Management added most to Salesforce in Q2 2021, an estimated $372M increase.
- Point72 Asset Management's biggest Q2 2021 reduction was Applied Materials, cutting an estimated $238M.
- Point72 Asset Management fully exited DXC Technology in Q2 2021, selling an estimated $235M.
- Point72 Asset Management's ten largest holdings make up 18% of its $22.3B portfolio in Q2 2021.
- Point72 Asset Management opened 347 new positions and closed 334 in Q2 2021.
- Point72 Asset Management's portfolio value rose 4% quarter-over-quarter to $22.3B.
Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.